Todos Med Ltd (TOMDF)

[Rayn_Makr]

The science targeting 3CL protease is compelling.

Todos has a nutritional supplement on the market and I would like GC to provide a chart on what that revenue stream has been over Q3 & Q4 of 2021. My first Tollovid (Amazon) order was $400, 2x $100 and 1x $200. I plan on repeating that quarterly. A Tollovid revenue projection for 2022 please. What does expansion into India and Asia look like for Tollovid?

I like to see multiple potential revenue streams with testing, therapeutics and supplements. Testing and therapeutics are capital intensive. They take time and a large corporate structure. They are both Highly Regulated Industries. Can Todos compete or partner with others that are willing to challenge more established organizations? I'm skeptical. That leaves the supplement business and it looks like that has huge potential. I hope there is a focus on that and the promotion of Tollovid is not limited to Twitter. Maybe Greece will get the ball rolling in Europe and serve as a model.

I also have invested in Revive Therapeutics, RVVTF, FWIW. Interesting patent: https://patentimages.storage.googleapis.com/00/63/f6/77b6de49e26bf7/WO2021184115A1.pdf